HealthEquity Financials - Benzinga

HealthEquity Inc

HQYNASDAQ

Trade with Public

Trade with Public

$102.79

0.460.45%

À la clôture: Aug 18, 5:00 PM EST

$102.79

N/A

Après les heures: 4:00 PM EST

Résultats: Résultats Q2 2027 dans dans 9 jours à partir de maintenant le jeu. août 27th, avant l'ouverture du marché

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

HealthEquity Financials

HealthEquity (HQY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

Benzinga Newsdesk

PRO
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

Benzinga Newsdesk

PRO
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate

Benzinga Newsdesk

HealthEquity Analysts Cut Their Forecasts After Q4 Results

HealthEquity Inc (NASDAQ: HQY) beat earnings expectations for Q4, with adjusted EPS of 95 cents. FY2027 guidance raised and analysts maintain ratings.

Avi Kapoor

PRO
HealthEquity Sees FY2027 GAAP EPS $2.78-$2.85 vs $2.67 Est; Sees Sales $1.405B-$1.415B

Benzinga Newsdesk

PRO
HealthEquity Sees FY2027 Adj EPS $4.56-$4.65 vs $4.54 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.405B-$1.415B vs $1.410B Est

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved